#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Alexander Chapman Email
SVP, Investor Relations and Corporate Communications . Poseida Therapeutics
How to contact Alexander Chapman
Join and see Alexander's contact info for free!Current Roles
Employees:
314Revenue:
$46.3MAbout
Poseida Therapeutics is translating best-in-class gene engineering technologies into lifesaving cell therapies. The company is developing CAR T-cell immunotherapies for multiple myeloma, prostate and other cancer types, as well as gene therapies for orphan diseases. P-BCMA-101 is Poseida's lead CAR-T therapy currently in Phase 1 clinical development for the treatment of multiple myeloma. Poseida has assembled a suite of industry-leading gene engineering technologies, including the piggyBac DNA Modification System, TAL-CLOVER and Cas-CLOVER site-specific nucleases, and Footprint-Free Gene Editing (FFGE). For more information, visit www.poseida.com.Poseida Therapeutics Address
9390 Towne Centre DriveSan Diego, CA
United States